Medical Care
Global Nanobiotechnology Market Research Report 2025
- Sep 06, 25
- ID: 492583
- Pages: 98
- Figures: 91
- Views: 3
This report aims to provide a comprehensive presentation of the global market for Nanobiotechnology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanobiotechnology.
The Nanobiotechnology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nanobiotechnology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nanobiotechnology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
Smith & Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Shire
Ipsen
Endo International
Segment by Type
Nanomedicine
Nano Medical Devices
Nano Diagnosis
Other
Segment by Application
Anticancer
CNS Product
Anti-infective
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nanobiotechnology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Nanobiotechnology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nanobiotechnology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nanobiotechnology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
Smith & Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Shire
Ipsen
Endo International
Segment by Type
Nanomedicine
Nano Medical Devices
Nano Diagnosis
Other
Segment by Application
Anticancer
CNS Product
Anti-infective
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nanobiotechnology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanobiotechnology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Nanomedicine
1.2.3 Nano Medical Devices
1.2.4 Nano Diagnosis
1.2.5 Other
1.3 Market by Application
1.3.1 Global Nanobiotechnology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Anticancer
1.3.3 CNS Product
1.3.4 Anti-infective
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nanobiotechnology Market Perspective (2020-2031)
2.2 Global Nanobiotechnology Growth Trends by Region
2.2.1 Global Nanobiotechnology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nanobiotechnology Historic Market Size by Region (2020-2025)
2.2.3 Nanobiotechnology Forecasted Market Size by Region (2026-2031)
2.3 Nanobiotechnology Market Dynamics
2.3.1 Nanobiotechnology Industry Trends
2.3.2 Nanobiotechnology Market Drivers
2.3.3 Nanobiotechnology Market Challenges
2.3.4 Nanobiotechnology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanobiotechnology Players by Revenue
3.1.1 Global Top Nanobiotechnology Players by Revenue (2020-2025)
3.1.2 Global Nanobiotechnology Revenue Market Share by Players (2020-2025)
3.2 Global Nanobiotechnology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nanobiotechnology Revenue
3.4 Global Nanobiotechnology Market Concentration Ratio
3.4.1 Global Nanobiotechnology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanobiotechnology Revenue in 2024
3.5 Global Key Players of Nanobiotechnology Head office and Area Served
3.6 Global Key Players of Nanobiotechnology, Product and Application
3.7 Global Key Players of Nanobiotechnology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanobiotechnology Breakdown Data by Type
4.1 Global Nanobiotechnology Historic Market Size by Type (2020-2025)
4.2 Global Nanobiotechnology Forecasted Market Size by Type (2026-2031)
5 Nanobiotechnology Breakdown Data by Application
5.1 Global Nanobiotechnology Historic Market Size by Application (2020-2025)
5.2 Global Nanobiotechnology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nanobiotechnology Market Size (2020-2031)
6.2 North America Nanobiotechnology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nanobiotechnology Market Size by Country (2020-2025)
6.4 North America Nanobiotechnology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nanobiotechnology Market Size (2020-2031)
7.2 Europe Nanobiotechnology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nanobiotechnology Market Size by Country (2020-2025)
7.4 Europe Nanobiotechnology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nanobiotechnology Market Size (2020-2031)
8.2 Asia-Pacific Nanobiotechnology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nanobiotechnology Market Size by Region (2020-2025)
8.4 Asia-Pacific Nanobiotechnology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nanobiotechnology Market Size (2020-2031)
9.2 Latin America Nanobiotechnology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nanobiotechnology Market Size by Country (2020-2025)
9.4 Latin America Nanobiotechnology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanobiotechnology Market Size (2020-2031)
10.2 Middle East & Africa Nanobiotechnology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nanobiotechnology Market Size by Country (2020-2025)
10.4 Middle East & Africa Nanobiotechnology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Nanobiotechnology Introduction
11.1.4 Amgen Revenue in Nanobiotechnology Business (2020-2025)
11.1.5 Amgen Recent Development
11.2 Teva Pharmaceuticals
11.2.1 Teva Pharmaceuticals Company Details
11.2.2 Teva Pharmaceuticals Business Overview
11.2.3 Teva Pharmaceuticals Nanobiotechnology Introduction
11.2.4 Teva Pharmaceuticals Revenue in Nanobiotechnology Business (2020-2025)
11.2.5 Teva Pharmaceuticals Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Nanobiotechnology Introduction
11.3.4 Abbott Revenue in Nanobiotechnology Business (2020-2025)
11.3.5 Abbott Recent Development
11.4 UCB
11.4.1 UCB Company Details
11.4.2 UCB Business Overview
11.4.3 UCB Nanobiotechnology Introduction
11.4.4 UCB Revenue in Nanobiotechnology Business (2020-2025)
11.4.5 UCB Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Nanobiotechnology Introduction
11.5.4 Roche Revenue in Nanobiotechnology Business (2020-2025)
11.5.5 Roche Recent Development
11.6 Celgene
11.6.1 Celgene Company Details
11.6.2 Celgene Business Overview
11.6.3 Celgene Nanobiotechnology Introduction
11.6.4 Celgene Revenue in Nanobiotechnology Business (2020-2025)
11.6.5 Celgene Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Nanobiotechnology Introduction
11.7.4 Sanofi Revenue in Nanobiotechnology Business (2020-2025)
11.7.5 Sanofi Recent Development
11.8 Merck & Co
11.8.1 Merck & Co Company Details
11.8.2 Merck & Co Business Overview
11.8.3 Merck & Co Nanobiotechnology Introduction
11.8.4 Merck & Co Revenue in Nanobiotechnology Business (2020-2025)
11.8.5 Merck & Co Recent Development
11.9 Biogen
11.9.1 Biogen Company Details
11.9.2 Biogen Business Overview
11.9.3 Biogen Nanobiotechnology Introduction
11.9.4 Biogen Revenue in Nanobiotechnology Business (2020-2025)
11.9.5 Biogen Recent Development
11.10 Stryker
11.10.1 Stryker Company Details
11.10.2 Stryker Business Overview
11.10.3 Stryker Nanobiotechnology Introduction
11.10.4 Stryker Revenue in Nanobiotechnology Business (2020-2025)
11.10.5 Stryker Recent Development
11.11 Gilead Sciences
11.11.1 Gilead Sciences Company Details
11.11.2 Gilead Sciences Business Overview
11.11.3 Gilead Sciences Nanobiotechnology Introduction
11.11.4 Gilead Sciences Revenue in Nanobiotechnology Business (2020-2025)
11.11.5 Gilead Sciences Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Nanobiotechnology Introduction
11.12.4 Pfizer Revenue in Nanobiotechnology Business (2020-2025)
11.12.5 Pfizer Recent Development
11.13 3M Company
11.13.1 3M Company Company Details
11.13.2 3M Company Business Overview
11.13.3 3M Company Nanobiotechnology Introduction
11.13.4 3M Company Revenue in Nanobiotechnology Business (2020-2025)
11.13.5 3M Company Recent Development
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Details
11.14.2 Johnson & Johnson Business Overview
11.14.3 Johnson & Johnson Nanobiotechnology Introduction
11.14.4 Johnson & Johnson Revenue in Nanobiotechnology Business (2020-2025)
11.14.5 Johnson & Johnson Recent Development
11.15 Smith & Nephew
11.15.1 Smith & Nephew Company Details
11.15.2 Smith & Nephew Business Overview
11.15.3 Smith & Nephew Nanobiotechnology Introduction
11.15.4 Smith & Nephew Revenue in Nanobiotechnology Business (2020-2025)
11.15.5 Smith & Nephew Recent Development
11.16 Leadiant Biosciences
11.16.1 Leadiant Biosciences Company Details
11.16.2 Leadiant Biosciences Business Overview
11.16.3 Leadiant Biosciences Nanobiotechnology Introduction
11.16.4 Leadiant Biosciences Revenue in Nanobiotechnology Business (2020-2025)
11.16.5 Leadiant Biosciences Recent Development
11.17 Kyowa Hakko Kirin
11.17.1 Kyowa Hakko Kirin Company Details
11.17.2 Kyowa Hakko Kirin Business Overview
11.17.3 Kyowa Hakko Kirin Nanobiotechnology Introduction
11.17.4 Kyowa Hakko Kirin Revenue in Nanobiotechnology Business (2020-2025)
11.17.5 Kyowa Hakko Kirin Recent Development
11.18 Shire
11.18.1 Shire Company Details
11.18.2 Shire Business Overview
11.18.3 Shire Nanobiotechnology Introduction
11.18.4 Shire Revenue in Nanobiotechnology Business (2020-2025)
11.18.5 Shire Recent Development
11.19 Ipsen
11.19.1 Ipsen Company Details
11.19.2 Ipsen Business Overview
11.19.3 Ipsen Nanobiotechnology Introduction
11.19.4 Ipsen Revenue in Nanobiotechnology Business (2020-2025)
11.19.5 Ipsen Recent Development
11.20 Endo International
11.20.1 Endo International Company Details
11.20.2 Endo International Business Overview
11.20.3 Endo International Nanobiotechnology Introduction
11.20.4 Endo International Revenue in Nanobiotechnology Business (2020-2025)
11.20.5 Endo International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanobiotechnology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Nanomedicine
1.2.3 Nano Medical Devices
1.2.4 Nano Diagnosis
1.2.5 Other
1.3 Market by Application
1.3.1 Global Nanobiotechnology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Anticancer
1.3.3 CNS Product
1.3.4 Anti-infective
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nanobiotechnology Market Perspective (2020-2031)
2.2 Global Nanobiotechnology Growth Trends by Region
2.2.1 Global Nanobiotechnology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nanobiotechnology Historic Market Size by Region (2020-2025)
2.2.3 Nanobiotechnology Forecasted Market Size by Region (2026-2031)
2.3 Nanobiotechnology Market Dynamics
2.3.1 Nanobiotechnology Industry Trends
2.3.2 Nanobiotechnology Market Drivers
2.3.3 Nanobiotechnology Market Challenges
2.3.4 Nanobiotechnology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanobiotechnology Players by Revenue
3.1.1 Global Top Nanobiotechnology Players by Revenue (2020-2025)
3.1.2 Global Nanobiotechnology Revenue Market Share by Players (2020-2025)
3.2 Global Nanobiotechnology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nanobiotechnology Revenue
3.4 Global Nanobiotechnology Market Concentration Ratio
3.4.1 Global Nanobiotechnology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanobiotechnology Revenue in 2024
3.5 Global Key Players of Nanobiotechnology Head office and Area Served
3.6 Global Key Players of Nanobiotechnology, Product and Application
3.7 Global Key Players of Nanobiotechnology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanobiotechnology Breakdown Data by Type
4.1 Global Nanobiotechnology Historic Market Size by Type (2020-2025)
4.2 Global Nanobiotechnology Forecasted Market Size by Type (2026-2031)
5 Nanobiotechnology Breakdown Data by Application
5.1 Global Nanobiotechnology Historic Market Size by Application (2020-2025)
5.2 Global Nanobiotechnology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nanobiotechnology Market Size (2020-2031)
6.2 North America Nanobiotechnology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nanobiotechnology Market Size by Country (2020-2025)
6.4 North America Nanobiotechnology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nanobiotechnology Market Size (2020-2031)
7.2 Europe Nanobiotechnology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nanobiotechnology Market Size by Country (2020-2025)
7.4 Europe Nanobiotechnology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nanobiotechnology Market Size (2020-2031)
8.2 Asia-Pacific Nanobiotechnology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nanobiotechnology Market Size by Region (2020-2025)
8.4 Asia-Pacific Nanobiotechnology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nanobiotechnology Market Size (2020-2031)
9.2 Latin America Nanobiotechnology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nanobiotechnology Market Size by Country (2020-2025)
9.4 Latin America Nanobiotechnology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanobiotechnology Market Size (2020-2031)
10.2 Middle East & Africa Nanobiotechnology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nanobiotechnology Market Size by Country (2020-2025)
10.4 Middle East & Africa Nanobiotechnology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Nanobiotechnology Introduction
11.1.4 Amgen Revenue in Nanobiotechnology Business (2020-2025)
11.1.5 Amgen Recent Development
11.2 Teva Pharmaceuticals
11.2.1 Teva Pharmaceuticals Company Details
11.2.2 Teva Pharmaceuticals Business Overview
11.2.3 Teva Pharmaceuticals Nanobiotechnology Introduction
11.2.4 Teva Pharmaceuticals Revenue in Nanobiotechnology Business (2020-2025)
11.2.5 Teva Pharmaceuticals Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Nanobiotechnology Introduction
11.3.4 Abbott Revenue in Nanobiotechnology Business (2020-2025)
11.3.5 Abbott Recent Development
11.4 UCB
11.4.1 UCB Company Details
11.4.2 UCB Business Overview
11.4.3 UCB Nanobiotechnology Introduction
11.4.4 UCB Revenue in Nanobiotechnology Business (2020-2025)
11.4.5 UCB Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Nanobiotechnology Introduction
11.5.4 Roche Revenue in Nanobiotechnology Business (2020-2025)
11.5.5 Roche Recent Development
11.6 Celgene
11.6.1 Celgene Company Details
11.6.2 Celgene Business Overview
11.6.3 Celgene Nanobiotechnology Introduction
11.6.4 Celgene Revenue in Nanobiotechnology Business (2020-2025)
11.6.5 Celgene Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Nanobiotechnology Introduction
11.7.4 Sanofi Revenue in Nanobiotechnology Business (2020-2025)
11.7.5 Sanofi Recent Development
11.8 Merck & Co
11.8.1 Merck & Co Company Details
11.8.2 Merck & Co Business Overview
11.8.3 Merck & Co Nanobiotechnology Introduction
11.8.4 Merck & Co Revenue in Nanobiotechnology Business (2020-2025)
11.8.5 Merck & Co Recent Development
11.9 Biogen
11.9.1 Biogen Company Details
11.9.2 Biogen Business Overview
11.9.3 Biogen Nanobiotechnology Introduction
11.9.4 Biogen Revenue in Nanobiotechnology Business (2020-2025)
11.9.5 Biogen Recent Development
11.10 Stryker
11.10.1 Stryker Company Details
11.10.2 Stryker Business Overview
11.10.3 Stryker Nanobiotechnology Introduction
11.10.4 Stryker Revenue in Nanobiotechnology Business (2020-2025)
11.10.5 Stryker Recent Development
11.11 Gilead Sciences
11.11.1 Gilead Sciences Company Details
11.11.2 Gilead Sciences Business Overview
11.11.3 Gilead Sciences Nanobiotechnology Introduction
11.11.4 Gilead Sciences Revenue in Nanobiotechnology Business (2020-2025)
11.11.5 Gilead Sciences Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Nanobiotechnology Introduction
11.12.4 Pfizer Revenue in Nanobiotechnology Business (2020-2025)
11.12.5 Pfizer Recent Development
11.13 3M Company
11.13.1 3M Company Company Details
11.13.2 3M Company Business Overview
11.13.3 3M Company Nanobiotechnology Introduction
11.13.4 3M Company Revenue in Nanobiotechnology Business (2020-2025)
11.13.5 3M Company Recent Development
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Details
11.14.2 Johnson & Johnson Business Overview
11.14.3 Johnson & Johnson Nanobiotechnology Introduction
11.14.4 Johnson & Johnson Revenue in Nanobiotechnology Business (2020-2025)
11.14.5 Johnson & Johnson Recent Development
11.15 Smith & Nephew
11.15.1 Smith & Nephew Company Details
11.15.2 Smith & Nephew Business Overview
11.15.3 Smith & Nephew Nanobiotechnology Introduction
11.15.4 Smith & Nephew Revenue in Nanobiotechnology Business (2020-2025)
11.15.5 Smith & Nephew Recent Development
11.16 Leadiant Biosciences
11.16.1 Leadiant Biosciences Company Details
11.16.2 Leadiant Biosciences Business Overview
11.16.3 Leadiant Biosciences Nanobiotechnology Introduction
11.16.4 Leadiant Biosciences Revenue in Nanobiotechnology Business (2020-2025)
11.16.5 Leadiant Biosciences Recent Development
11.17 Kyowa Hakko Kirin
11.17.1 Kyowa Hakko Kirin Company Details
11.17.2 Kyowa Hakko Kirin Business Overview
11.17.3 Kyowa Hakko Kirin Nanobiotechnology Introduction
11.17.4 Kyowa Hakko Kirin Revenue in Nanobiotechnology Business (2020-2025)
11.17.5 Kyowa Hakko Kirin Recent Development
11.18 Shire
11.18.1 Shire Company Details
11.18.2 Shire Business Overview
11.18.3 Shire Nanobiotechnology Introduction
11.18.4 Shire Revenue in Nanobiotechnology Business (2020-2025)
11.18.5 Shire Recent Development
11.19 Ipsen
11.19.1 Ipsen Company Details
11.19.2 Ipsen Business Overview
11.19.3 Ipsen Nanobiotechnology Introduction
11.19.4 Ipsen Revenue in Nanobiotechnology Business (2020-2025)
11.19.5 Ipsen Recent Development
11.20 Endo International
11.20.1 Endo International Company Details
11.20.2 Endo International Business Overview
11.20.3 Endo International Nanobiotechnology Introduction
11.20.4 Endo International Revenue in Nanobiotechnology Business (2020-2025)
11.20.5 Endo International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Nanobiotechnology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Nanomedicine
Table 3. Key Players of Nano Medical Devices
Table 4. Key Players of Nano Diagnosis
Table 5. Key Players of Other
Table 6. Global Nanobiotechnology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Nanobiotechnology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Nanobiotechnology Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Nanobiotechnology Market Share by Region (2020-2025)
Table 10. Global Nanobiotechnology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Nanobiotechnology Market Share by Region (2026-2031)
Table 12. Nanobiotechnology Market Trends
Table 13. Nanobiotechnology Market Drivers
Table 14. Nanobiotechnology Market Challenges
Table 15. Nanobiotechnology Market Restraints
Table 16. Global Nanobiotechnology Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Nanobiotechnology Market Share by Players (2020-2025)
Table 18. Global Top Nanobiotechnology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanobiotechnology as of 2024)
Table 19. Ranking of Global Top Nanobiotechnology Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Nanobiotechnology Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Nanobiotechnology, Headquarters and Area Served
Table 22. Global Key Players of Nanobiotechnology, Product and Application
Table 23. Global Key Players of Nanobiotechnology, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Nanobiotechnology Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Nanobiotechnology Revenue Market Share by Type (2020-2025)
Table 27. Global Nanobiotechnology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Nanobiotechnology Revenue Market Share by Type (2026-2031)
Table 29. Global Nanobiotechnology Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Nanobiotechnology Revenue Market Share by Application (2020-2025)
Table 31. Global Nanobiotechnology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Nanobiotechnology Revenue Market Share by Application (2026-2031)
Table 33. North America Nanobiotechnology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Nanobiotechnology Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Nanobiotechnology Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Nanobiotechnology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Nanobiotechnology Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Nanobiotechnology Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Nanobiotechnology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Nanobiotechnology Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Nanobiotechnology Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Nanobiotechnology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Nanobiotechnology Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Nanobiotechnology Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Nanobiotechnology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Nanobiotechnology Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Nanobiotechnology Market Size by Country (2026-2031) & (US$ Million)
Table 48. Amgen Company Details
Table 49. Amgen Business Overview
Table 50. Amgen Nanobiotechnology Product
Table 51. Amgen Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 52. Amgen Recent Development
Table 53. Teva Pharmaceuticals Company Details
Table 54. Teva Pharmaceuticals Business Overview
Table 55. Teva Pharmaceuticals Nanobiotechnology Product
Table 56. Teva Pharmaceuticals Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 57. Teva Pharmaceuticals Recent Development
Table 58. Abbott Company Details
Table 59. Abbott Business Overview
Table 60. Abbott Nanobiotechnology Product
Table 61. Abbott Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 62. Abbott Recent Development
Table 63. UCB Company Details
Table 64. UCB Business Overview
Table 65. UCB Nanobiotechnology Product
Table 66. UCB Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 67. UCB Recent Development
Table 68. Roche Company Details
Table 69. Roche Business Overview
Table 70. Roche Nanobiotechnology Product
Table 71. Roche Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 72. Roche Recent Development
Table 73. Celgene Company Details
Table 74. Celgene Business Overview
Table 75. Celgene Nanobiotechnology Product
Table 76. Celgene Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 77. Celgene Recent Development
Table 78. Sanofi Company Details
Table 79. Sanofi Business Overview
Table 80. Sanofi Nanobiotechnology Product
Table 81. Sanofi Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 82. Sanofi Recent Development
Table 83. Merck & Co Company Details
Table 84. Merck & Co Business Overview
Table 85. Merck & Co Nanobiotechnology Product
Table 86. Merck & Co Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 87. Merck & Co Recent Development
Table 88. Biogen Company Details
Table 89. Biogen Business Overview
Table 90. Biogen Nanobiotechnology Product
Table 91. Biogen Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 92. Biogen Recent Development
Table 93. Stryker Company Details
Table 94. Stryker Business Overview
Table 95. Stryker Nanobiotechnology Product
Table 96. Stryker Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 97. Stryker Recent Development
Table 98. Gilead Sciences Company Details
Table 99. Gilead Sciences Business Overview
Table 100. Gilead Sciences Nanobiotechnology Product
Table 101. Gilead Sciences Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 102. Gilead Sciences Recent Development
Table 103. Pfizer Company Details
Table 104. Pfizer Business Overview
Table 105. Pfizer Nanobiotechnology Product
Table 106. Pfizer Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 107. Pfizer Recent Development
Table 108. 3M Company Company Details
Table 109. 3M Company Business Overview
Table 110. 3M Company Nanobiotechnology Product
Table 111. 3M Company Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 112. 3M Company Recent Development
Table 113. Johnson & Johnson Company Details
Table 114. Johnson & Johnson Business Overview
Table 115. Johnson & Johnson Nanobiotechnology Product
Table 116. Johnson & Johnson Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 117. Johnson & Johnson Recent Development
Table 118. Smith & Nephew Company Details
Table 119. Smith & Nephew Business Overview
Table 120. Smith & Nephew Nanobiotechnology Product
Table 121. Smith & Nephew Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 122. Smith & Nephew Recent Development
Table 123. Leadiant Biosciences Company Details
Table 124. Leadiant Biosciences Business Overview
Table 125. Leadiant Biosciences Nanobiotechnology Product
Table 126. Leadiant Biosciences Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 127. Leadiant Biosciences Recent Development
Table 128. Kyowa Hakko Kirin Company Details
Table 129. Kyowa Hakko Kirin Business Overview
Table 130. Kyowa Hakko Kirin Nanobiotechnology Product
Table 131. Kyowa Hakko Kirin Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 132. Kyowa Hakko Kirin Recent Development
Table 133. Shire Company Details
Table 134. Shire Business Overview
Table 135. Shire Nanobiotechnology Product
Table 136. Shire Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 137. Shire Recent Development
Table 138. Ipsen Company Details
Table 139. Ipsen Business Overview
Table 140. Ipsen Nanobiotechnology Product
Table 141. Ipsen Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 142. Ipsen Recent Development
Table 143. Endo International Company Details
Table 144. Endo International Business Overview
Table 145. Endo International Nanobiotechnology Product
Table 146. Endo International Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 147. Endo International Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Nanobiotechnology Picture
Figure 2. Global Nanobiotechnology Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nanobiotechnology Market Share by Type: 2024 VS 2031
Figure 4. Nanomedicine Features
Figure 5. Nano Medical Devices Features
Figure 6. Nano Diagnosis Features
Figure 7. Other Features
Figure 8. Global Nanobiotechnology Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Nanobiotechnology Market Share by Application: 2024 VS 2031
Figure 10. Anticancer Case Studies
Figure 11. CNS Product Case Studies
Figure 12. Anti-infective Case Studies
Figure 13. Other Case Studies
Figure 14. Nanobiotechnology Report Years Considered
Figure 15. Global Nanobiotechnology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Nanobiotechnology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Nanobiotechnology Market Share by Region: 2024 VS 2031
Figure 18. Global Nanobiotechnology Market Share by Players in 2024
Figure 19. Global Top Nanobiotechnology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanobiotechnology as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Nanobiotechnology Revenue in 2024
Figure 21. North America Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Nanobiotechnology Market Share by Country (2020-2031)
Figure 23. United States Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Nanobiotechnology Market Share by Country (2020-2031)
Figure 27. Germany Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Nanobiotechnology Market Share by Region (2020-2031)
Figure 35. China Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Nanobiotechnology Market Share by Country (2020-2031)
Figure 43. Mexico Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Nanobiotechnology Market Share by Country (2020-2031)
Figure 47. Turkey Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Amgen Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 51. Teva Pharmaceuticals Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 52. Abbott Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 53. UCB Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 54. Roche Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 55. Celgene Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 56. Sanofi Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 57. Merck & Co Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 58. Biogen Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 59. Stryker Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 60. Gilead Sciences Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 61. Pfizer Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 62. 3M Company Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 63. Johnson & Johnson Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 64. Smith & Nephew Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 65. Leadiant Biosciences Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 66. Kyowa Hakko Kirin Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 67. Shire Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 68. Ipsen Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 69. Endo International Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Table 1. Global Nanobiotechnology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Nanomedicine
Table 3. Key Players of Nano Medical Devices
Table 4. Key Players of Nano Diagnosis
Table 5. Key Players of Other
Table 6. Global Nanobiotechnology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Nanobiotechnology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Nanobiotechnology Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Nanobiotechnology Market Share by Region (2020-2025)
Table 10. Global Nanobiotechnology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Nanobiotechnology Market Share by Region (2026-2031)
Table 12. Nanobiotechnology Market Trends
Table 13. Nanobiotechnology Market Drivers
Table 14. Nanobiotechnology Market Challenges
Table 15. Nanobiotechnology Market Restraints
Table 16. Global Nanobiotechnology Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Nanobiotechnology Market Share by Players (2020-2025)
Table 18. Global Top Nanobiotechnology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanobiotechnology as of 2024)
Table 19. Ranking of Global Top Nanobiotechnology Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Nanobiotechnology Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Nanobiotechnology, Headquarters and Area Served
Table 22. Global Key Players of Nanobiotechnology, Product and Application
Table 23. Global Key Players of Nanobiotechnology, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Nanobiotechnology Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Nanobiotechnology Revenue Market Share by Type (2020-2025)
Table 27. Global Nanobiotechnology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Nanobiotechnology Revenue Market Share by Type (2026-2031)
Table 29. Global Nanobiotechnology Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Nanobiotechnology Revenue Market Share by Application (2020-2025)
Table 31. Global Nanobiotechnology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Nanobiotechnology Revenue Market Share by Application (2026-2031)
Table 33. North America Nanobiotechnology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Nanobiotechnology Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Nanobiotechnology Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Nanobiotechnology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Nanobiotechnology Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Nanobiotechnology Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Nanobiotechnology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Nanobiotechnology Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Nanobiotechnology Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Nanobiotechnology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Nanobiotechnology Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Nanobiotechnology Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Nanobiotechnology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Nanobiotechnology Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Nanobiotechnology Market Size by Country (2026-2031) & (US$ Million)
Table 48. Amgen Company Details
Table 49. Amgen Business Overview
Table 50. Amgen Nanobiotechnology Product
Table 51. Amgen Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 52. Amgen Recent Development
Table 53. Teva Pharmaceuticals Company Details
Table 54. Teva Pharmaceuticals Business Overview
Table 55. Teva Pharmaceuticals Nanobiotechnology Product
Table 56. Teva Pharmaceuticals Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 57. Teva Pharmaceuticals Recent Development
Table 58. Abbott Company Details
Table 59. Abbott Business Overview
Table 60. Abbott Nanobiotechnology Product
Table 61. Abbott Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 62. Abbott Recent Development
Table 63. UCB Company Details
Table 64. UCB Business Overview
Table 65. UCB Nanobiotechnology Product
Table 66. UCB Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 67. UCB Recent Development
Table 68. Roche Company Details
Table 69. Roche Business Overview
Table 70. Roche Nanobiotechnology Product
Table 71. Roche Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 72. Roche Recent Development
Table 73. Celgene Company Details
Table 74. Celgene Business Overview
Table 75. Celgene Nanobiotechnology Product
Table 76. Celgene Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 77. Celgene Recent Development
Table 78. Sanofi Company Details
Table 79. Sanofi Business Overview
Table 80. Sanofi Nanobiotechnology Product
Table 81. Sanofi Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 82. Sanofi Recent Development
Table 83. Merck & Co Company Details
Table 84. Merck & Co Business Overview
Table 85. Merck & Co Nanobiotechnology Product
Table 86. Merck & Co Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 87. Merck & Co Recent Development
Table 88. Biogen Company Details
Table 89. Biogen Business Overview
Table 90. Biogen Nanobiotechnology Product
Table 91. Biogen Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 92. Biogen Recent Development
Table 93. Stryker Company Details
Table 94. Stryker Business Overview
Table 95. Stryker Nanobiotechnology Product
Table 96. Stryker Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 97. Stryker Recent Development
Table 98. Gilead Sciences Company Details
Table 99. Gilead Sciences Business Overview
Table 100. Gilead Sciences Nanobiotechnology Product
Table 101. Gilead Sciences Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 102. Gilead Sciences Recent Development
Table 103. Pfizer Company Details
Table 104. Pfizer Business Overview
Table 105. Pfizer Nanobiotechnology Product
Table 106. Pfizer Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 107. Pfizer Recent Development
Table 108. 3M Company Company Details
Table 109. 3M Company Business Overview
Table 110. 3M Company Nanobiotechnology Product
Table 111. 3M Company Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 112. 3M Company Recent Development
Table 113. Johnson & Johnson Company Details
Table 114. Johnson & Johnson Business Overview
Table 115. Johnson & Johnson Nanobiotechnology Product
Table 116. Johnson & Johnson Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 117. Johnson & Johnson Recent Development
Table 118. Smith & Nephew Company Details
Table 119. Smith & Nephew Business Overview
Table 120. Smith & Nephew Nanobiotechnology Product
Table 121. Smith & Nephew Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 122. Smith & Nephew Recent Development
Table 123. Leadiant Biosciences Company Details
Table 124. Leadiant Biosciences Business Overview
Table 125. Leadiant Biosciences Nanobiotechnology Product
Table 126. Leadiant Biosciences Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 127. Leadiant Biosciences Recent Development
Table 128. Kyowa Hakko Kirin Company Details
Table 129. Kyowa Hakko Kirin Business Overview
Table 130. Kyowa Hakko Kirin Nanobiotechnology Product
Table 131. Kyowa Hakko Kirin Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 132. Kyowa Hakko Kirin Recent Development
Table 133. Shire Company Details
Table 134. Shire Business Overview
Table 135. Shire Nanobiotechnology Product
Table 136. Shire Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 137. Shire Recent Development
Table 138. Ipsen Company Details
Table 139. Ipsen Business Overview
Table 140. Ipsen Nanobiotechnology Product
Table 141. Ipsen Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 142. Ipsen Recent Development
Table 143. Endo International Company Details
Table 144. Endo International Business Overview
Table 145. Endo International Nanobiotechnology Product
Table 146. Endo International Revenue in Nanobiotechnology Business (2020-2025) & (US$ Million)
Table 147. Endo International Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Nanobiotechnology Picture
Figure 2. Global Nanobiotechnology Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nanobiotechnology Market Share by Type: 2024 VS 2031
Figure 4. Nanomedicine Features
Figure 5. Nano Medical Devices Features
Figure 6. Nano Diagnosis Features
Figure 7. Other Features
Figure 8. Global Nanobiotechnology Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Nanobiotechnology Market Share by Application: 2024 VS 2031
Figure 10. Anticancer Case Studies
Figure 11. CNS Product Case Studies
Figure 12. Anti-infective Case Studies
Figure 13. Other Case Studies
Figure 14. Nanobiotechnology Report Years Considered
Figure 15. Global Nanobiotechnology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Nanobiotechnology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Nanobiotechnology Market Share by Region: 2024 VS 2031
Figure 18. Global Nanobiotechnology Market Share by Players in 2024
Figure 19. Global Top Nanobiotechnology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanobiotechnology as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Nanobiotechnology Revenue in 2024
Figure 21. North America Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Nanobiotechnology Market Share by Country (2020-2031)
Figure 23. United States Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Nanobiotechnology Market Share by Country (2020-2031)
Figure 27. Germany Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Nanobiotechnology Market Share by Region (2020-2031)
Figure 35. China Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Nanobiotechnology Market Share by Country (2020-2031)
Figure 43. Mexico Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Nanobiotechnology Market Share by Country (2020-2031)
Figure 47. Turkey Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Amgen Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 51. Teva Pharmaceuticals Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 52. Abbott Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 53. UCB Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 54. Roche Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 55. Celgene Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 56. Sanofi Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 57. Merck & Co Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 58. Biogen Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 59. Stryker Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 60. Gilead Sciences Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 61. Pfizer Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 62. 3M Company Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 63. Johnson & Johnson Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 64. Smith & Nephew Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 65. Leadiant Biosciences Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 66. Kyowa Hakko Kirin Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 67. Shire Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 68. Ipsen Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 69. Endo International Revenue Growth Rate in Nanobiotechnology Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232